Zhejiang Xianju Pharmaceutical (002332.SZ) and related personnel received a warning letter from the Zhejiang Securities Regulatory Bureau.

Zhejiang Xianju Pharmaceutical (002332.SZ) announced that the company recently received an administrative regulatory measure decision from the Zhejiang Regulatory Bureau of the China Securities Regulatory Commission, titled "Decision on Issuing a Warning Letter to Zhejiang Xianju Pharmaceutical Co., Ltd. and Related Personnel". During an on-site inspection, the Zhejiang Regulatory Bureau found the following issues in the company's management and use of raised funds: Some raised funds were used without following the required approval procedures and disclosure, raised funds were used to pay for expenses unrelated to the raised investment projects, and there was commingling of raised funds and company's own funds when purchasing bank structured deposit financial products with unused raised funds.